Are you ready to dive into the future of medicine and the revolutionary advancements being made with artificial intelligence? In this episode, I sit down with Alex Zhavoronkov, the founder and CEO of Insilico Medicine, a global company focused on the discovery of novel therapeutics utilizing cutting-edge technology in healthcare.
From longevity research to anti-aging treatments, Alex shares his expertise on the
most impactful field of our time, discussing his work in protein target
discovery and the design of small molecule drugs using generative AI.
But it doesn't stop there. Alex also shares insights into the development of aging
clocks, biomarkers of aging, and precision medicine. Discover how generative AI
is transforming the pharmaceutical industry, improving clinical trials, and
providing a revolutionary new approach to drug discovery methods.
Don't miss out on this incredible opportunity to learn from one of the leading
experts in AI and healthcare innovation. Tune in now and join us on this
fascinating journey into the future of medicine.
đź’ˇ LINKS TO MORE CONTENT
If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribe
Watch on Youtube
Alex Zhavoronkov
Christian Soschner
Check out the organizations that make the podcast possible
đź“– Memorable quotes:
(10:50) “Insilico Medicine synthesized and tested the first AI generated drug in 2017.”
(23:09) “Generative AI in Drug Discovery and Drug Development has the potential to improve the probability of success by 50%”
(24:00) “Generating 11 preclinical candidates in 2.5 years - is a pretty cool number.”
(29:48) “We developed a clinical candidate in 18 months at a 3 million dollar cost with the help of AI. The traditional route takes 2 years at about 400 million expeonses.”
(01:08:48) “Generative AI will transform our lives beyond recognition in every way.”
⏰ Timestamps:
(02:00) Introduction to Alex Zhavoronkov at World Government Summit 2023Â
(03:00) About World Government Summit 2023Â
(04:20) Alex's longevity research at Insilico MedicineÂ
(08:20) Accelerating drug discovery with AIÂ
(13:00) AI in synthetic biologic dataÂ
(15:00) Generative AI in reducing cost and increasing outputÂ
(23:30) Generative AI in increasing probability of successÂ
(25:00) Why traditional drug R&D takes over 10 years and 2 billion 2010 dollarsÂ
(28:45) AI-driven drug discovery at Insilico MedicineÂ
(30:30) Insilico Medicine's pipeline and case studyÂ
(38:09) Regulators' perception of AI in drug developmentÂ
(45:26) Generative AI in clinical development
 (49:15) Audience question on AI and microbiome researchÂ
(53:30) Operating a company between China, Middle East, and North AmericaÂ
(57:54) Insilico Medicine's fully a
How to Start a Podcast Guide: The Complete GuideListen on: Apple Podcasts Spotify
Support the Show.
Join the Podcast Newsletter: Link
#66 - Martin Popilka, Denis Roio - This was 2021 - A year in Review 7/7
#65 - Paul Polterauer, Philipp Peinsold, Markus Raunig - This was 2021 - A year in Review 6/7
#64: Walter Stockinger, Yoni Falkson - This was 2021 - A Year in Review Part 5/7
#63: Albert Missbichler, Peter Llewellyn-Davies - This was 2021 - A Year in Review Part 4/7
#62: Christian Soschner, Johannes Sarx, Philipp Hainzl, Stefanie Rösel, Julia Resch - This was 2021 - A Year in Review Part 3/7
#61: Bettina Resl, Sascha Berger,Tilmann Buerckstuemmer, Thomas Moser, Kimberly Cornfield - This was 2021 - A Year in Review Part 2/7
#60: Astrid Woollard, Dusica Lukac, Matthias Tarasiewicz, Irénée Robin - This was 2021 - A Year in Review Part 1/7
#59: Sascha Berger - TVM Capital - A Perspective on The Life-Science-Eco-System in the US and Europe
#58: Bettina Resl - Trends in the Pharma Industry in the 21st Century
#57: JaromĂr Zahrádka - Bridging Science and Business in the European Life Science Eco-System
#56: Ole Dammann - How to Do Clinical Research in Europe
#55: Peter Llewellyn-Davies - The Future of Life Science Entrepreneurship and Investment in Europe
#54: Oliver Mavher and Michael Deichsel - Crypto Trading and Taxes - The Past, The Present, and The Future
#53: Alexander Schwartz and Ingrid Kelly Spillman - The Future of Early-Stage Deep Tech Investments in Europe
#52: Caroline Heil - Driving the Future of Meat
#51: Saara Inkinen - The Future of Tech Transfer in a Post-Pandemic World
#50: Dimitrios Tzalis - Insights Into Building CROs in Asia and in Europe
#49: Andrea Sommer - Marrying Deeptech with IP Strategy
#48: Kurt Höller & Joy Cürten EIT - Health & The International Healthtech Revolution
#47: Sebastien Groyer - 7 Tales from 20 years of Deep Tech Life Science Venture Capital Investment
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
Organic Marketing Simplified: Master podcast marketing, fuel podcast growth, and make money podcasting!
THE GO BIZ GUY
The Sigma Femme Podcast
The Prof G Pod with Scott Galloway
The Tim Ferriss Show